Hsu Jason (CIK 1895035) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-29). Recent activity: Buy IMMX (6,250 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-29 | Immix Biopharma, Inc. (IMMX) | Director | Buy | 6,250 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-29